SCHEMBL10195141

SCHEMBL10195141

CCc1ccc(Oc2ccc(F)cc2F)cc1C1=C(O)CC(C)(C)CC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.43
HSPB1 P04792 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
HTR2A P28223 2/20 0.36
SLC6A4 P31645 2/20 0.36
KCNH2 Q12809 2/20 0.36
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 1/20 0.36
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TRPA1 O75762 1/20 0.35
MEN1 O00255 1/20 0.35
PSMD14 O00487 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.34
GHSR Q92847 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16351661 0.92 ALDH1A1 (0.36) MAPK14SMN1; SMN2HTR2ASLC6A4KCNH2
SCHEMBL10195111 0.91 SLC6A4 (0.40) MAPK14SMN1; SMN2HIF1AHTR2ASLC6A4
SCHEMBL10195143 0.91 MAPT (0.36) MAPK14SMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL10195172 0.90 SLC6A4 (0.41) MAPK14SMN1; SMN2HIF1AHTR2ASLC6A4
SCHEMBL10195109 0.89 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1KDM4ETSHRCASP1
SCHEMBL10195192 0.88 ALDH1A1 (0.34) MAPK14SMN1; SMN2HTR2ASLC6A4KCNH2
SCHEMBL10195171 0.84 MAPK14 (0.46) MAPK14HSPB1HIF1AHTR2ASLC6A4
SCHEMBL16351678 0.84 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KDM4ETSHRCASP1
SCHEMBL10194979 0.83 SMN1; SMN2 (0.39) SMN1; SMN2HIF1AHTR2ASLC6A4KCNH2
SCHEMBL10195451 0.83 SMN1; SMN2 (0.39) SMN1; SMN2HIF1AHTR2ASLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAPK14 2943/4885HSPB1 1790/4885SMN1; SMN2 2218/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAPK14 2378/4885HSPB1 1045/4885SMN1; SMN2 2952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.